Sanders Corazon (Corsee) D. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$199,377.87

Insider Activity of Sanders Corazon (Corsee) D.

According to the SEC Form 4 filings, Sanders Corazon (Corsee) D., being in a position of

  1. director at BeOne Medicines AG,
    оver the last 12 months, has bought 0 shares, and sold 2839 shares for $961,167,
    over all time since 2025-09-05, has bought 0 shares, and sold 5504 shares for $1.86M.

Biography of Sanders Corazon (Corsee) D.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,270,1884100

Comparison of Insiders on Amount of Buys and Sells

2026-09-29SaleLegend Biotech Corporation
LEGN
director
27,370
0.0074%
$9.46$258,920+1.17%
2026-06-15SaleUltragenyx Pharmaceutical Inc.
RARE
director
2,000
0.0021%
$25.05$50,100-0.45%
2026-05-22SaleBeOne Medicines Ltd.
ONC
director
212
0.0002%
$309.59$65,633+12.25%
2025-11-26SaleBeOne Medicines Ltd.
ONC
director
2,627
0.0025%
$340.90$895,534-5.95%
2025-09-05SaleBeOne Medicines Ltd.
ONC
director
2,665
0.0025%
$337.00$898,105-6.79%
2025-06-20SaleUltragenyx Pharmaceutical Inc.
RARE
director
2,405
0.0026%
$37.39$89,923-26.45%
2024-07-02SaleUltragenyx Pharmaceutical Inc.
RARE
director
584
0.0007%
$40.98$23,932+6.53%
2024-06-10SaleUltragenyx Pharmaceutical Inc.
RARE
director
1,737
0.002%
$41.10$71,391+4.12%
2023-06-30SaleUltragenyx Pharmaceutical Inc.
RARE
director
585
0.0008%
$46.76$27,355-9%
2023-06-08SaleUltragenyx Pharmaceutical Inc.
RARE
director
1,485
0.0021%
$51.65$76,700-16.61%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.